Literature DB >> 7532682

Fas-mediated cytotoxicity by freshly isolated natural killer cells.

H Arase1, N Arase, T Saito.   

Abstract

The expression of Fas ligand on natural killer (NK) cells and Fas-mediated cytotoxicity by NK cells was investigated. Fas ligand mRNA was expressed in freshly isolated NK cells but not in T cells. Furthermore, the Fas ligand was detected on the cell surface of NK cells by staining with soluble Fas molecule. We analyzed the cytolytic activity of NK cells against thymocyte targets from normal and lpr mice, and found that the NK cells killed thymocytes from normal mice but not from lpr mice. On the other hand, splenic T cells did not show any cytotoxicity against either of the thymocyte targets. Similarly, NK cells exhibited cytotoxicity against transfectants expressing Fas antigen but not against parental cells or transfectants expressing a mutant Fas antigen with deleted cytoplasmic region. These results demonstrated that NK cells express Fas ligand and possess the capability of killing target cells expressing Fas antigen on their surface. This finding suggests that NK cells play an important role by eliminating Fas-expressing cells either constitutively or inducibly in peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532682      PMCID: PMC2191925          DOI: 10.1084/jem.181.3.1235

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  NK cell-sensitive T-cell subpopulation in thymus: inverse correlation to host NK activity.

Authors:  M Hansson; R Kiessling; B Andersson; K Kärre; J Roder
Journal:  Nature       Date:  1979-03-08       Impact factor: 49.962

2.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

Authors:  R Watanabe-Fukunaga; C I Brannan; N Itoh; S Yonehara; N G Copeland; N A Jenkins; S Nagata
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

3.  MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.

Authors:  N S Liao; M Bix; M Zijlstra; R Jaenisch; D Raulet
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

4.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

5.  Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes.

Authors:  H Arase; N Arase-Fukushi; R A Good; K Onoé
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.

Authors:  P Höglund; C Ohlén; E Carbone; L Franksson; H G Ljunggren; A Latour; B Koller; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.

Authors:  J Hackett; M Tutt; M Lipscomb; M Bennett; G Koo; V Kumar
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

9.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

10.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  66 in total

1.  Ablation of a specific cell population by the replacement of a uniquely expressed gene with a toxin gene.

Authors:  K Arase; K Saijo; H Watanabe; A Konno; H Arase; T Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Serum levels of soluble Fas ligand in patients with silicosis.

Authors:  A Tomokuni; T Otsuki; Y Isozaki; S Kita; H Ueki; M Kusaka; T Kishimoto; A Ueki
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 4.  Fas (CD95, Apo-1) ligand gene transfer.

Authors:  S E Lamhamedi-Cherradi; Y Chen
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

5.  IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

Authors:  J M Wigginton; E Gruys; L Geiselhart; J Subleski; K L Komschlies; J W Park; T A Wiltrout; K Nagashima; T C Back; R H Wiltrout
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 6.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

7.  Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model.

Authors:  Junjie Wu; David J Waxman
Journal:  Cancer Lett       Date:  2014-07-25       Impact factor: 8.679

8.  Expression of apoptosis-related proteins in rat with induced colitis.

Authors:  Giuseppe D'Argenio; Maria Grazia Farrace; Vittorio Cosenza; Francesca De Ritis; Nicola Della Valle; Francesco Manguso; Mauro Piacentini
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

9.  Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.

Authors:  Y Onoe; M Harada; K Tamada; K Abe; T Li; H Tada; K Nomoto
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.

Authors:  N Fujioka; R Akazawa; K Ohashi; M Fujii; M Ikeda; M Kurimoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.